Document is current
Any future updates will be listed below
-
Authors
Valle-Hita, Cristina
Joensen, Andrea
Bjerregaard, Anne Ahrendt
Babio, Nancy
Strandberg-Larsen, Katrine
Guasch-Ferré, Marta
-
Funding
Funding for this research was provided by:
Generalitat de Catalunya (2022 FI_B100108)
Danmarks Frie Forskningsfond (DFF-8045-00047B)
Novo Nordisk Fonden (NNF23SA0084103)
- License Information
-
More Information
Article History
Received: 11 November 2025
Accepted: 20 December 2025
First Online: 20 January 2026
Declarations
:
: All authors declare no conflict of interest.
: The DNBC cohort is approved by the Danish Data Protection Agency under the general approval granted to Statens Serum Institut (fællesfortegnelse), reference number 18/04608 and by the Committee on Health Research Ethics (case number (KF) 01-471/94). Participants in the DNBC were enrolled with informed consent and individuals born into the cohort were notified about their participation, rights and the option to opt out upon turning 18. Data approval for the analyses conducted in this study, which involved linking DNBC data with register data accessed on Statistics Denmark’s server, was obtained from the DNBC managerial team (2018-15), Statistics Denmark and registered under the Danish Data Protection Agency’s general approval for the Faculty of Health and Medical Sciences at the University of Copenhagen (514–0400/19-3000). This study was conducted with compliance with the Declaration of Helsinki.
